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Foot and Leg Muscle Weakness in People With Midfoot 
Osteoarthritis
John B. Arnold,1  Jill Halstead,2  Andrew J. Grainger,3 Anne- Maree Keenan,4 Catherine L. Hill,5 and 
Anthony C. Redmond4
Objective. To compare foot and leg muscle strength in people with symptomatic midfoot osteoarthritis (OA) with 
asymptomatic controls, and to determine the association between muscle strength, foot pain, and disability.
Methods. Participants with symptomatic midfoot OA and asymptomatic controls were recruited for this cross- 
sectional study from general practices and community health clinics. The maximum isometric muscle strength 
of the ankle plantarflexors, dorsiflexors, invertors and evertors, and the hallux and lesser toe plantarflexors was 
measured using hand- held dynamometry. Self- reported foot pain and foot- related disability were assessed with 
the Manchester Foot Pain and Disability Index. Differences in muscle strength were compared between groups. 
Multivariable regression was used to determine the association between muscle strength, foot pain, and disability 
after adjusting for covariates.
Results. People with midfoot OA (n = 52) exhibited strength deficits in all muscle groups, ranging from 19% 
(dorsiflexors) to 30% (invertors) relative to the control group (n = 36), with effect sizes of 0.6– 1.1 (P < 0.001). In 
those with midfoot OA, ankle invertor muscle strength was negatively and independently associated with foot pain 
(β = – 0.026 [95% confidence interval (95% CI) – 0.051, – 0.001]; P = 0.045). Invertor muscle strength was negatively 
associated with foot- related disability, although not after adjustment for depressive symptoms (β = – 0.023 [95% CI 
– 0.063, 0.017]; P = 0.250).
Conclusion. People with symptomatic midfoot OA demonstrate weakness in the foot and leg muscles compared 
to asymptomatic controls. Preliminary indications from this study suggest that strengthening of the foot and leg 
muscles may offer potential to reduce pain and improve function in people with midfoot OA.
INTRODUCTION
Foot osteoarthritis (OA) is a common cause of foot pain in 
older adults, affecting 1 in 6 adults ages >50 years in the UK (1). 
One of the most frequent presentations is symptomatic midfoot 
OA (12%), which affects the talonavicular (5.8%), navicular- first 
cuneiform (5.2%), or cuneometatarsal joints (3.9– 6.8%) (2). Mid-
foot OA is associated with significant pain (2,3) and difficulty in 
walking (3) and climbing stairs (4). Severe midfoot OA may cause 
foot deformity, changes in foot posture, and difficulty with finding 
suitable footwear (5). Symptoms appear to change little over time, 
with midfoot OA causing persistent foot pain and foot- related dis-
ability over 18 months (6).
Demonstrated risk factors for midfoot OA include female 
sex, age, obesity, intermediate/routine occupational class, previ-
ous foot/ankle injury, and pain in other weight- bearing joints (2). 
Within the foot, midfoot OA is associated with bony malalignment, 
resulting in reduced medial longitudinal arch height (7) and a more 
pronated foot posture (8). This is accompanied by reduced sag-
ittal plane range- of- motion in the medial longitudinal arch (4) and 
The views expressed herein are those of the authors and do not 
necessarily represent those of the NHS, the NIHR, Health Education England, 
or the Department of Health.
Supported by the NIHR Leeds Biomedical Research Centre, the Leeds 
Experimental Osteoarthritis Treatment Centre funded by Arthritis Research 
UK (grant 20083), and the NIHR Clinical Research Network. Dr. Arnold is 
a National Health and Medical Research Council of Australia Early Career 
research fellow (ID: 1120560). Dr. Halstead’s work was supported by the 
Health Education England/NIHR Integrated Clinical Academic Programme 
Bridging Scheme. Drs. Redmond and Keenan are NIHR senior investigators.
1John B. Arnold, PhD: University of Leeds, NIHR Leeds Biomedical Research 
Centre, Leeds, UK, and University of South Australia, Adelaide, South Australia; 
2Jill Halstead, PhD, FFPM (Glas), RCPS: University of Leeds, NIHR Leeds 
Biomedical Research Centre and Leeds Community Healthcare NHS Trust, 
Leeds, UK; 3Andrew J. Grainger, BM, BS, FRCR, FRCP: University of Leeds, NIHR 
Leeds Biomedical Research Centre, Leeds Teaching Hospitals NHS Trust, Leeds, 
UK; 4Anne- Maree Keenan, PhD, FFPM, RCPS (Glas), Anthony C. Redmond, PhD, 
FFPM, RCPS (Glas), FCPM: University of Leeds, NIHR Leeds Biomedical Research 
Centre, Leeds, UK; 5Catherine L. Hill, MBBS, MD, MSc, FACP: The Queen 
Elizabeth Hospital and University of Adelaide, Adelaide, South Australia.
No potential conflicts of interest relevant to this article were reported.
Address correspondence to John B. Arnold, PhD, School of Health 
Sciences, University of South Australia, City East Campus, Adelaide, South 
Australia 5001, Australia. Email: john.arnold@unisa.edu.au.
Submitted for publication September 26, 2019; accepted in revised form 
March 3, 2020.
MUSCLE STRENGTH IN MIDFOOT OSTEOARTHRITIS |      773
elevated forces and pressures under the midfoot during walking 
(7,9). Despite a growing understanding of the clinical features and 
functional consequences of midfoot OA, previous studies have 
focused on selected structural and biomechanical components, 
such as radiographic alignment, foot motion, and plantar pres-
sures. Given the importance of muscle strength for joint stability 
and control, and the relationship between muscle weakness and 
OA in other joints (10,11), understanding muscle function in mid-
foot OA warrants further investigation. To the best of our knowl-
edge, however, no studies have investigated muscle strength in 
people with midfoot OA.
Muscle weakness is a hallmark of OA at other joints such 
as the hip (10), knee (12), and hand (13) and is associated with 
pain (14), joint instability (15), and performance- based (15) and 
self- reported physical function (16). Deficits in muscle strength 
appear early in OA (17) and, in the knee, have been associated 
with incident radiographic disease (18) as well as symptomatic 
and functional decline (11). Muscle strengthening exercises are a 
core component of OA management and are included in interna-
tional clinical guidelines (19– 21). There is, however, little research 
on muscle strength in people with foot OA, particularly in midfoot 
OA. One prior study of first metatarsophalangeal joint OA inves-
tigated the relationship between symptoms and demographic 
and clinical characteristics, including plantarflexion strength of the 
hallux (22). This study showed that hallux plantarflexion strength 
was negatively, although weakly, associated with first metatar-
sophalangeal joint pain. Whether foot and leg muscle weakness 
is present in people with midfoot OA has not been investigated. 
Furthermore, whether muscle strength is associated with patient- 
reported outcomes in midfoot OA, such as pain and function, has 
not been evaluated. Greater understanding of whether foot and 
leg muscle weakness is a feature of midfoot OA has potential clin-
ical implications, as muscle strength is modifiable (23) and may 
be a viable target for treatment. Pain and disability are the main 
reasons why people with OA seek treatment (24), therefore identi-
fication of the factors associated with symptoms has the potential 
to improve the design of treatments for this condition.
The aims of this study were to compare foot and 
leg muscle strength in people with symptomatic midfoot OA with 
asymptomatic controls and to determine whether muscle strength 
was associated with self- reported pain and foot- related disability. 
It was hypothesised a priori that people with midfoot pain and OA 
would present with foot and leg muscle weakness, and that mus-
cle strength would be negatively associated with pain and foot- 
related disability.
PATIENTS AND METHODS
Study design and recruitment. This was a cross- 
sectional study involving people with midfoot pain and OA and 
asymptomatic controls. Participants were recruited from the com-
munity via advertisements, general practitioners, and health clin-
ics. Ethics approval was obtained from the Leeds East Research 
Ethics Committee (17/YH/0261). All participants provided written 
informed consent prior to their involvement.
Participants. Symptomatic participants were ages >40 
years, had pain in the midfoot for >3 months with an average 
weekly pain severity of ≥3 of 10 on an 11- point numerical rat-
ing scale (NRS) that occurred with or worsened following weight- 
bearing activities. The presence of midfoot pain was confirmed 
by participants marking the site of pain on a foot manikin (25,26), 
and supplemented by clinical examination to assess whether pain 
was reported on palpation of the talonavicular (TNJ), navicular- 
cuneiform (NCJ), or cuneiform- metatarsal (CMJ) joints. Weight- 
bearing dorsoplantar and lateral radiographs were used to grade 
OA in either the TNJ, NCJ, or first or second CMJ by a mus-
culoskeletal radiologist (AJG) using the La Trobe Foot Atlas (27). 
An established case definition was used, where a joint was con-
sidered to have OA with a score of ≥2 for osteophytes or joint 
space narrowing (JSN) on either the dorsoplantar or lateral views 
(27). To establish intrarater reliability, scoring was repeated on 20 
participants, 3 months apart, without reference to the first set of 
scores. Exclusion criteria were >30 minutes of early morning stiff-
ness in the feet, inflammatory arthritis, muscle or connective tissue 
disease, neurologic conditions, corticosteroid injection to the foot 
in the past 6 months, stress fracture or history of foot surgery, 
or contraindications to radiographs. Concurrent knee or hip pain 
was permitted if the pain intensity was not greater than their mid-
foot pain and was quiescent (average daily pain less than midfoot 
pain and <2 in the past week on NRS).
Control group participants were required to be age >40 years 
and free from foot or lower extremity joint pain. This was verified 
using an 11- point NRS for foot pain and a body pain manikin. 
Additional exclusion criteria for controls were presence of radi-
ographic OA (osteophytes or JSN >1 on either view in any of 
the midfoot joints [TNJ, NCJ, first or second CMJ]), contraindica-
tions to radiograph, inflammatory arthritis, muscle or connective 
tissue disease, neurologic conditions, stress fracture, or lower 
extremity bone or joint surgery in the past 12 months. A meaning-
ful a priori sample size calculation was not performed due to the 
SIGNIFICANCE & INNOVATIONS
• To the best of our knowledge, this study is the first 
investigation of foot muscle strength in people with 
midfoot osteoarthritis and its relationship to foot 
pain and foot- related disability.
• Foot and leg muscle strength is reduced in all mus-
cle groups in people with midfoot osteoarthritis 
compared to asymptomatic controls.
• Muscle strength was independently and inversely 
related to foot pain in people with midfoot osteoar-
thritis.
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lack of prior research on muscle strength in people with midfoot 
OA. Therefore, the sample size, including unbalanced sampling of 
controls, was dictated by the period of recruitment for this study 
(12 months) and available funding.
Muscle strength testing. The maximal isometric strength 
of the leg and foot muscles was measured using a CITEC hand- 
held dynamometer (CIT Technics). The device has a range of 
0– 500 newtons (N) and, according to manufacturer’s data, was 
factory- calibrated to a sensitivity of 0.1%. Testing was performed 
by an experienced clinician (JBA) using standardized protocols, 
which have well- established intrarater (intraclass correlation coef-
ficient [ICC] 0.83– 0.94) and interrater reliability (ICC 0.77– 0.88) 
(28). All testing was performed by the same researcher, with the 
participants in a supine position and the lower extremity stabilized 
proximal to the ankle joint. The muscle groups that were evaluated 
included ankle plantarflexors, dorsiflexors, invertors and evertors, 
hallux plantarflexors, and lesser toe plantarflexors.
For plantarflexion strength, the dynamometer was positioned 
on the plantar surface of the foot just proximal to the first metatar-
sal head, and for dorsiflexion it was placed on the dorsal surface 
of the foot just proximal to the metatarsal heads. To prevent move-
ment during plantarflexion strength tests, the examiner anchored 
the dynamometer on the anterior aspect of the participants’ thigh. 
For inversion, the dynamometer was placed on the medial border 
of the foot at the midpoint of the shaft of the first metatarsal, and 
for eversion it was placed on the lateral border of the foot over 
the midpoint of the fifth metatarsal. Hallux plantarflexor strength 
involved positioning of the dynamometer on the plantar surface 
of the interphalangeal joint and on the plantar surface of the toes 
for lesser toe strength. To standardize joint position across feet 
of different sizes with the same dynamometer, both the hallux 
and lesser toes were dorsiflexed into the participants comforta-
ble end range of motion, as per the original protocol (28). The 
ankle was also placed in a plantarflexion during testing of the hal-
lux and lesser toe muscles to prevent co- contraction of the ankle 
plantarflexors.
Before testing, the required movement was passively 
demonstrated by the examiner. This was followed by asking the 
participants to perform the movement against the dynamometer 
to ensure the correct action could be performed. The “make” 
technique was used requiring participants to exert a maximum 
voluntary contraction (MVC) against the dynamometer. Three valid 
MVCs of 3– 5 seconds were obtained for each muscle group, with 
15 seconds rest in between each trial (29). Verbal encourage-
ment was standardized during the contractions, with the exam-
iner telling each participant to “go ahead- push- push- push- push 
and relax” (30). The mean value of 3 trials was used for analy-
sis (28). For participants with OA, the symptomatic side was the 
index foot; in cases of bilateral OA, only the most painful foot was 
tested. For controls, the right side was tested. To account for any 
differences in height or weight between groups, muscle strength 
data (in newtons) were normalized to body mass multiplied by 
height (% weight × height).
Foot pain and disability assessment. Pain severity in the 
past week, past month, and while walking was documented with 
an 11- point NRS for each, ranging from 0 (no pain) to 10 (worst 
pain imaginable). Pain and foot- related disability were assessed 
using the Manchester Foot Pain and Disability Index (MFPDI) (31), 
a 19- item questionnaire with subscales of foot pain (5 items), 
disability (10 items), appearance (2 items), and work or leisure (2 
items). Each item is scored from 0 (none of the time) to 2 (on most 
days/every day). Pain subscale scores range from 0 to 10 and 
function scores from 0 to 20, with higher scores indicating more 
pain or worse foot- related disability. The MFPDI, which has been 
previously used in people with midfoot OA (2,3,6), displays good 
construct validity and internal consistency (31). Prior to analysis, 
raw scores were converted to Rasch- transformed interval level 
scores.
Other clinical characteristics. Due to the relationship 
and importance of depression to the development and experi-
ence of foot pain (32,33), information on depressive symptoms 
was obtained by participants completing the Hospital Anxiety and 
Depression Scale (HADS) (34), a 14- item questionnaire with 7 of 
these items relating to depressive symptoms (scored 0– 3) with a 
total subscale score ranging 0– 21. The psychometric properties of 
the HADS have been previously established (35). Questionnaires 
were also administered to capture general (EuroQol 5- domain) 
(36) and OA- specific (OA- QoL) health- related quality of life (37). 
Foot posture was quantified using the 6- item version of the Foot 
Posture Index (FPI- 6), a validated and reliable clinical measure of 
foot posture (38,39). Each participant’s foot posture (total score 
for the index foot) was classified according to cut points from nor-
mative data as supinated (score <0), normal (0– 5), or pronated 
(≥6) (40).
Statistical analysis. Descriptive statistics were generated 
for participant characteristics, symptoms (pain NRS and MFPDI), 
and muscle strength scores. Normal distributions for muscle 
strength, pain NRS, and MFPDI scores were determined using 
histograms and Shapiro- Wilks tests. Independent sample t- tests 
and chi- square tests were used to compare participant charac-
teristics and muscle strength between the midfoot pain and OA 
and asymptomatic control groups. Equality of variances was con-
firmed with Levene’s test. Consistent with previous studies in foot 
OA (1), for the primary analysis the case definition for absence of 
radiographic OA in the midfoot included JSN or osteophyte grade 
of <2. We also conducted a further sensitivity analysis to evaluate 
differences in muscle strength between the midfoot OA group and 
asymptomatic controls using definitions of grade 0 (n = 19) and 
grade >0 (n = 17) for JSN or osteophytes in the midfoot joints. Dif-
ferences in muscle strength were also summarized as percentage 
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difference (%) and with standardized effect sizes (Cohen’s d coef-
ficient). Intrarater reliability of radiographic scoring of foot OA was 
determined using percent of agreement and weighted kappa with 
quadratic weights.
Pearson’s correlation coefficients were used to determine the 
strength and direction of the univariable relationship between mus-
cle strength and MFPDI pain and function. Multivariable linear 
regression was used to determine the association between muscle 
strength and MFPDI pain (model 1) and MFPDI function (model 2), 
with age, sex, and body mass index (BMI) as covariates. To avoid 
issues with multicollinearity of predictors in the multivariable models, 
only the muscle strength group that displayed the strongest univari-
ate relationship with MFPDI pain and function scores was included 
in the model. Due to the relationship between depression and pain, 
the depressive symptoms score was also entered into each model. 
We also adjusted for radiographic disease severity in the midfoot, 
represented by the total sum score of JSN and osteophytes for the 
TNJ, NCJ, and first and second CMJ. Results are presented as 
adjusted unstandardized regression coefficients (β) with 95% con-
fidence intervals (95% CIs). The amount of variance explained by 
each model was determined using the adjusted r2. All assumptions 
for the regression analyses were tested and met, including linearity 
of relationships and independence, homoscedasticity, and normal-
ity of residuals. Statistical significance was set at P less than 0.05. 
All analyses were conducted using SPSS, version 21.
RESULTS
Descriptive characteristics. Fifty- two people with mid-
foot OA and 36 asymptomatic controls completed all testing 
(Table 1). The mean age of the midfoot OA group was 62 years 
(73% women), with a BMI of 29.2 kg/m2, compared to the asympto-
matic controls (mean age 63 years, 66% women, BMI 27.2 kg/m2). 
There were no statistically significant differences in age, sex, or 
BMI between groups (P > 0.05).
Clinical characteristics. The midfoot OA group 
reported moderate levels of pain over the past 24 hours 
(mean ± SD 3.7 ± 2.2), with slightly higher average pain over the 
past week (mean ± SD 4.2 ± 32.2) and while walking (mean ± SD 
Table 1. Descriptive and clinical characteristics of midfoot OA and control groups*
Midfoot OA  
group (n = 52)
Control  
group (n = 36) P
Age, years 62.2 ±11.4 63.6 ± 11.7 0.586
Female sex, % 73 66 0.517
BMI (kg/m2) 29.2 ± 5.4 27.2 ± 4.8 0.053
Joint- specific radiographic OA, no. (%)†
Talonavicular joint 11 (21) – 
Navicular-­first­cuneiform­joint 21 (40) – 
First cuneiform- metatarsal joint 18 (35) – 
Second cuneiform- metatarsal joint 38 (73) – 
Foot pain and functional limitation
Dorsal midfoot pain, no. (%) 42 (81) – 
Plantar midfoot pain, no. (%) 10 (19) – 
Foot pain severity
Average in past 24 hours (0– 10 NRS) 3.7 ± 2.2 – 
Average in past week (0– 10 NRS) 4.2 ± 2.2 – 
On walking in past week (0– 10 NRS) 5.0 ± 2.6 – 
MFPDI Rasch pain‡ 5.95 ± 1.6 – 
MFPDI Rasch function‡ 8.62 ± 3.0 – 
Quality of life and mental health
OA quality of life§ 5.52 ± 5.9 1.08 ± 2.5 <0.001
EQ overall health (0– 100)¶ 68.30 ± 20.9 86.72 ± 11.9 <0.001
HADS depression# 3.87 ± 5.4 1.94 ± 3.0 0.035
HADS anxiety# 5.31 ± 6.0 3.72 ± 3.7 0.131
Foot Posture Index**
Supinated (<0), no. (%) 4 (8) 7 (19)
Normal (0– 5), no. (%) 19 (36) 18 (50)
Pronated­(≥6),­no.­(%) 29 (56) 11 (31) 0.044
* Values are the mean ± SD unless indicated otherwise. BMI = body mass index; EQ = 
EuroQol; HADS = Hospital Anxiety and Depression Scale; MFPDI = Manchester Foot Pain 
and Disability Index; NRS = numerical rating scale; OA = osteoarthritis. 
† Joint- specific OA does not equal 100%, as >1 midfoot joint may have OA. 
‡ Higher values indicate more foot pain or foot- related disability. 
§ Higher values indicate poorer OA-related quality of life. 
¶ Higher values indicate better health- related quality of life. 
# Higher values indicate more depression or anxiety symptoms. 
** Foot Posture Index scores are for the study foot only. 
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5.0 ± 2.6). Most participants reported dorsally located midfoot 
pain (81%) compared to plantar midfoot pain (19%). Thirty par-
ticipants with midfoot OA had unilateral midfoot pain (57%), and 
43% had bilateral midfoot pain. Radiographic OA was most com-
monly present in the second CMJ (73%), followed by the NCJ 
(40%), first CMJ (35%), and TNJ (21%). Intrarater reliability of radi-
ographic scoring was almost perfect (percent agreement = 92%; 
κW = 0.92 [95% CI 0.90, 0.95]). People with OA reported poorer 
OA- specific and general health- related quality of life, as well as 
a higher level of depressive symptoms, compared to asympto-
matic controls. A greater proportion of people with midfoot OA 
had a pronated foot posture (FPI ≥6) compared to controls, with 
fewer in the normal and supinated categories (Table 1).
Muscle strength. People with midfoot pain and OA dis-
played strength deficits in all muscle groups compared to asymp-
tomatic controls (Table 2). The magnitude of weakness ranged 
from 19% (dorsiflexion) to 30% (inversion), equating to effect 
sizes of Cohen’s d coefficient = 0.6 to 1.1 (Figure 1). Except for 
ankle dorsiflexion, differences existed regardless of whether peo-
ple with midfoot OA were compared to controls with grade 0 for 
JSN or osteophytes (n = 19) or with those with grade >0 (n = 17) 
(P < 0.001– 0.079) (see Supplementary Table 1, available on the 
Arthritis Care & Research website at http://onlin elibr ary.wiley.com/
doi/10.1002/acr.24182/ abstract).
Relationship between muscle strength, pain, and 
function. In bivariate analyses, muscle strength was negatively 
correlated with pain and foot- related disability for all muscle groups 
(Table 3) except for hallux plantarflexion strength and MFPDI pain. 
Ankle invertor muscle strength was most strongly associated with 
both MFPDI pain (r = – 0.320, P = 0.027) (Figure 2) and MFPDI 
function (r = – 0.349, P = 0.015).
Multivariable associations between invertor muscle 
strength, MFPDI pain, and MFPDI function are presented in 
Table 4. Multivariable regression analysis revealed that ankle 
invertor muscle strength was independently associated with 
foot pain (β = – 0.026 [95% CI – 0.051, – 0.001]; P = 0.045) 
after adjusting for age, sex, BMI, radiograph severity, and 
depressive symptoms (Table 4). Depressive symptoms were 
positively associated with pain (β = 0.127 [95% CI 0.004, 
0.251]; P = 0.044). Invertor muscle strength was also neg-
atively associated with foot- related disability (β = – 0.023 
[95% CI – 0.063, 0.017]; P = 0.250) (Table 4), although not 
after adjusting for the HADS depression domain, which was 
positively associated with foot- related disability (β = 0.286 
Table 2. Comparison of foot and leg muscle strength between people with midfoot pain and 
osteoarthritis (OA) and asymptomatic controls*
Muscle strength  
(% weight × height)










Ankle plantarflexion 141 ± 48† 192 ± 61 26 0.9 <0.001
Ankle dorsiflexion 88 ± 33† 109 ± 30 19 0.6 <0.001
Ankle inversion 62 ± 22‡ 89 ± 28 30 1.1 <0.001
Ankle eversion 67 ± 20† 90 ± 27 26 1.0 <0.001
Lesser toes plantarflexion 62 ± 20† 79 ± 23 22 0.8 <0.001
Hallux plantarflexion 62 ± 19† 85 ± 26 27 1.0 <0.001
* Values are the mean ± SD unless indicated otherwise. Percent difference is calculated relative to 
asymptomatic controls. 
† n = 50, as 2 participants limited by pain on movement. 
‡ n = 48, as 4 participants limited by pain on movement. 
Figure 1. Box plot showing the muscle strength (% body weight [BW] × height [Ht]) for foot and leg muscle groups for midfoot osteoarthritis 
(OA) and control participants. Horizontal lines and error bars show the median and interquartile range. Dotted lines indicate mean value with 
corresponding effect size (Cohen’s d coefficient) and P for differences in mean between groups for each variable.
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[95% CI 0.092, 0.480]; P = 0.005). As lesser toe plantarflex-
ion and ankle eversion strength were significantly associated 
with foot- related disability in univariate analyses (Table 3), we 
substituted these variables in the multivariable analyses, and 
they were found not to be associated with pain or foot- related 
disability (data not shown). The total variance explained by the 
independent variables of age, sex, BMI, radiograph severity, 
invertor strength, and depressive symptoms was 14% for foot 
pain and 29% for foot- related disability.
DISCUSSION
In this study, we aimed to compare foot and leg muscle 
strength in people with symptomatic midfoot OA and healthy con-
trols, and to determine whether muscle strength was associated 
with self- reported pain and foot- related disability. Our primary 
hypothesis was confirmed; we found that muscle strength was 
impaired in all muscle groups by 19% to 30% in people with mid-
foot OA. Our secondary hypothesis that muscle strength would 
be cross- sectionally associated with foot pain and foot- related 
disability was partially supported. Invertor muscle strength was 
independently associated with pain after adjustment for covari-
ates. Although invertor strength was negatively associated with 
foot- related disability, this association was not statistically signifi-
cant after adjustment for depressive symptoms.
Muscle weakness has been identified as a clinical feature 
of OA at other lower extremity joints, including the hip (10), knee 
(12), and hand (13). This is the first published study to investi-
gate muscle strength in midfoot OA. Reductions in maximal iso-
metric strength were observed across all foot and leg muscle 
groups in people with midfoot OA, with the largest differences in 
the ankle invertor group. This may be expected, given that radi-
ographic midfoot OA was present in the joints along the medial 
arch (TNJ, NCJ, first and second CMJ) (1), where the tibialis pos-
terior muscle (a primary hindfoot invertor) attaches to the adja-
cent tarsal bones and metatarsals. Deficits in intrinsic foot muscle 
strength were observed, including muscles that flex the lesser 
toes and hallux, which are responsible for stiffening the metatarso-
phalangeal joints to facilitate push- off during walking (41). We did 
not objectively quantify physical performance, but these findings 
suggest that muscle weakness in the foot and leg may partially 
explain deficits in functional ability seen in people with midfoot OA, 
such as difficulty walking and descending stairs (3,4).
Evidence from longitudinal studies undertaken in knee OA 
suggests that reduced knee extensor muscle strength is asso-
ciated with incident tibiofemoral OA (18) and increased risk of 
symptomatic and functional decline, particularly in women (11). 
Although it is plausible that muscle weakness plays a role in the 
pathogenesis of midfoot OA, there are other factors that require 
consideration. For example, in hand OA, the relationship between 
grip strength and incident radiographic OA differed by site (met-
acarpal, proximal, and distal interphalangeal joints), and higher 
grip strength was associated with incident disease in men but not 
women (42). The impact of muscle weakness on structural dis-
ease in midfoot OA may also be joint specific, and the impact on 
prognosis may differ according to the site of foot OA, which tends 
to cluster in the midfoot and first metatarsophalangeal joint (3). 
The interaction of muscle strength and malalignment may also be 
important, particularly as people with midfoot OA have flatter feet 
than asymptomatic controls (7). As this study was cross- sectional, 
we were not able to determine the temporal nature of the relation-
ship between muscle weakness and midfoot OA. Future prospec-
tive longitudinal studies in foot OA would be beneficial to clarify the 
nature and strength of these relationships.
The relationship between muscle weakness, foot pain, and 
self- reported function is complex and multifactorial. In this study, 
the models only explained a modest amount of variance in pain 
Figure 2. Relationship between invertor muscle strength (% weight 
[Wt] × height [Ht]) and Manchester Foot Pain and Disability Index 
(MFPDI) pain in people with midfoot osteoarthritis. Circles represent 
individual participants in the midfoot OA group.
Table 3. Univariate relationships between foot and leg isometric 
muscle strength variables and Manchester Foot Pain and Disability 
Index (MFPDI) pain and function subscales
Muscle strength  
(% body­weight ×­height)
MFPDI pain MFPDI function
r P r P
Ankle plantarflexion* – 0.034 0.813 – 0.221 0.122
Ankle dorsiflexion* – 0.176 0.222 – 0.155 0.282
Ankle inversion† – 0.320 0.027 – 0.349 0.015‡
Ankle eversion* – 0.178 0.216 – 0.303 0.033‡
Lesser toes plantarflexion* – 0.279 0.053 – 0.346 0.015‡
Hallux plantarflexion* 0.043 0.767 – 0.125 0.387
* n = 50, as 2 participants limited by pain on movement. 
† n = 48, as 4 participants limited by pain on movement. 
‡ P < 0.05. 
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(14%) and foot- related disability (29%), with radiographic OA 
score not independently associated with either outcome. We also 
determined that deficits in muscle strength in people with midfoot 
OA existed compared to controls regardless of whether the con-
trols demonstrated minor incidental radiographic features of midfoot 
OA. This suggests that pain, rather than established radiographic 
features, likely explained the differences in this model. These results 
are consistent with other sites of small- joint OA, such as the hand, 
where radiographic OA explains only a small amount of variance of 
hand pain and physical function (43,44), with pain mediating the rela-
tionship between radiographic disease and self- reported function 
and strength (43). Studies using magnetic resonance imaging (MRI) 
and ultrasound- detected OA features, which indicate OA disease 
activity, have revealed stronger associations between bone marrow 
lesions and synovitis with pain and function (45,46). Relationships 
between MRI- detected features of foot OA and symptoms are yet 
to be explored but offer an opportunity to focus on earlier disease.
Strengthening exercises are associated with moderate 
improvements in pain, function, physical performance, and small 
improvements in quality of life compared to usual care in peo-
ple with hip and knee OA (47). Exercises for hand OA promot-
ing strengthening and joint stability have shown small beneficial 
effects on pain, function, and joint stiffness, with few adverse 
events, although overall the quality of evidence is low (48). Given 
existing knowledge of the role of exercise for people with OA 
in other joints, further studies appear warranted to investigate 
whether muscle strengthening is a feasible and effective method 
to decrease pain and improve function in people with midfoot OA. 
Importantly, person- level psychosocial factors also influence the 
report of symptoms, with numerous studies identifying poorer 
psychological well- being to be associated with the development 
(49) and severity (32) of persistent foot pain. Our study in midfoot 
OA was able to examine the influence of depressive symptoms on 
pain and function and found independent associations for both 
outcomes, underscoring the importance of psychosocial factors 
in foot OA.
There are limitations to this study. Muscle strength assess-
ment was conducted with the examiner aware of the participant’s 
clinical status. Blinding is difficult, if not impossible, to achieve 
when participants have OA involving pain and deformity. 
To mitigate this difficulty, we used standardized, reliable proto-
cols to obtain maximum force output from participants during 
testing. To be included in the control group, participants had to 
show grade 0 or 1 changes for JSN or osteophytes in all the mid-
foot joints. While this is the usual accepted criteria for absence of 
OA, 17 participants had grade 1 for either JSN or osteophytes in 
the midfoot. These participants were confirmed, however, to have 
no foot symptoms or history of foot injury likely to predispose them 
to OA. The sample size for the control group was chosen to be as 
large as could be practically achieved within the time and resource 
constraints, and consequently the control group included fewer 
participants than the OA group. Although we adjusted for impor-
tant confounders of foot pain in the multivariable analyses, the 
number of participants with midfoot OA also limited the number 
of independent variables included in the models. Given that the 
amount of explained variance in pain and function in the multivari-
able analysis was low, other factors not investigated are likely to be 
associated with foot pain and foot- related disability in midfoot OA.
In conclusion, people with symptomatic midfoot OA 
demonstrate weakness in the foot and leg muscles compared 
to asymptomatic controls. In those with midfoot pain and OA, 
ankle invertor muscle strength was independently and nega-
tively associated with pain after adjusting for covariates. Ankle 
invertor strength was also associated with foot- related disa-
bility, however, not after adjusting for depressive symptoms. 
Longitudinal studies are required to establish whether foot and 
Table 4. Relationship between invertor muscle strength and Manchester Foot 




95% CI Pβ SE
Model 1: pain
Age – 0.012 0.027 – 0.066, 0.042 0.660
Sex 0.234 0.566 – 0.910, 1.378 0.682
BMI – 0.049 0.055 – 0.159, 0.061 0.374
Invertor strength – 0.026 0.013 – 0.051, – 0.001 0.045†
Radiograph severity 0.070 0.044 – 0.018, 0.159 0.117
Depressive symptoms 0.127 0.061 0.004, 0.251 0.044*
Model 2: function
Age 0.074 0.042 – 0.010, 0.159 0.081
Sex 1.030 0.886 – 0.759, 2.820 0.252
BMI 0.077 0.085 – 0.095, 0.250 0.370
Invertor strength – 0.023 0.020 – 0.063, 0.017 0.250
Radiograph severity – 0.041 0.069 – 0.180, 0.098 0.555
Depressive symptoms 0.286 0.096 0.092, 0.480 0.005*
* 95% CI = 95% confidence interval; BMI = body mass index. 
† P < 0.05. 
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leg muscle weakness has implications for structural and symp-
tomatic decline. Strengthening of the foot and leg muscles may 
offer potential to reduce pain and improve function in people 
with midfoot OA.
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